Read More Pharma Industry News Clearmind Medicine receives IRB approval in Israel for Phase 1/2a trial targeting alcohol use disorder Clearmind Medicine wins IRB nod in Israel for its psychedelic-based AUD trial. Find out how this pivotal study could reshape addiction treatment. byPallavi MadhirajuJuly 3, 2025